Key result
Cardiorenal syndrome management centers on optimizing intravascular volume and renal perfusion despite limited definitive evidence.
Highlights the pathophysiological complexity of cardiorenal syndrome and emphasizes the need for future heart failure trials to include patients with advanced kidney disease.
Volume optimization remains central amid evidentiary gaps in cardiorenal syndrome; leaves open optimal strategies for future trials including advanced CKD.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Martínez-Santos et al. (2011) conducted a review in Cardiorenal Syndrome. Cardiorenal syndrome management was evaluated. Management of cardiorenal syndrome involves targeting adequate intravascular volume and ensuring proper renal perfusion, despite the lack of definitive evidence-based therapeutic strategies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: